AREXVY
Vaccine against Respiratory Syncytial Virus (RSV)
AREXVY is a vaccine intended to protect against respiratory syncytial virus (RSV). It is primarily intended for older adults and people with chronic medical conditions, in whom an RSV infection can lead to severe illness, pneumonia, or worsening of heart or lung disease. The vaccine is administered by intramuscular injection into the upper arm.
Vaccination Schedule
One dose of the vaccine is administered.
Vaccination is recommended especially for older adults and patients with chronic lung or heart disease, diabetes, or a weakened immune system. It is best to get vaccinated before the start of the RSV season, ideally in late summer or fall.
When to Postpone Vaccination
It is advisable to postpone vaccination in the event of an acute febrile illness or if a doctor determines that the patient’s current health condition is not suitable for vaccination. After vaccination, it is recommended to avoid excessive physical exertion on the day of vaccination and to follow your usual rest regimen.
The Most Common Side Effects
The most common side effects are pain, redness, or swelling at the injection site. Fatigue, headache, muscle or joint pain, or a slightly elevated body temperature may occur temporarily. These symptoms usually go away on their own within a few days.
Pregnancy and Breastfeeding
AREXVY is not intended for use in pregnant women to protect the newborn. A doctor will determine whether vaccination is appropriate during pregnancy or while breastfeeding based on an individual assessment of the patient’s health and the expected benefits of vaccination.
Notice
Vaccination significantly reduces the risk of severe RSV infection, but it does not provide 100 percent protection.
All information provided on this page is for informational purposes only and is not a substitute for a personal consultation with a doctor. A doctor will always determine the appropriateness of vaccination, the choice of vaccine, and the vaccination schedule based on your current health status, age, planned travel, and individual risks.